Literature DB >> 29933897

Assessment of liver disease in cystic fibrosis.

Suzanne Davison1.   

Abstract

Liver disease in cystic fibrosis has many causes, with biliary fibrosis due to abnormal CFTR protein predominating. Assessment requires aetiology to be defined. Biliary fibrosis may progress to cirrhosis and portal hypertension, which although initially asymptomatic, may cause varices and splenomegaly. Monitoring progression includes clinical and ultrasound assessment with endoscopic assessment of varices for those at risk. Extrapolated primarily from longitudinal assessment of viral hepatitis in adults, non-invasive elastography has a potential role. Evidence is lacking to support intervention strategies, but ursodeoxycholic acid and ligation of varices are widely applied. Indication and timing of liver transplantation are not clearly defined. Multidisciplinary approach is needed to tailor assessment and guide management.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis liver disease; Liver transplantation; Oesophageal varices; Portal hypertension

Mesh:

Substances:

Year:  2018        PMID: 29933897     DOI: 10.1016/j.prrv.2018.05.010

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  4 in total

Review 1.  Hepatic Manifestations of Cystic Fibrosis.

Authors:  Sasan Sakiani; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Clin Liver Dis       Date:  2019-02-21       Impact factor: 6.126

2.  Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study.

Authors:  Elham Shakerian; Reza Afarin; Rasoul Akbari; Narges Mohammadtaghvaei
Journal:  Mol Biol Rep       Date:  2022-01-24       Impact factor: 2.316

3.  Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Authors:  Ning Liu; Jiao Feng; Xiya Lu; Zhilu Yao; Qing Liu; Yang Lv; Yuru Han; Jingfan Deng; Yingqun Zhou
Journal:  Mediators Inflamm       Date:  2019-07-31       Impact factor: 4.711

4.  Saikosaponin-d alleviates hepatic fibrosis through regulating GPER1/autophagy signaling.

Authors:  Yirong Chen; Renye Que; Na Zhang; Liubing Lin; Mengen Zhou; Yong Li
Journal:  Mol Biol Rep       Date:  2021-10-29       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.